Home › NDC Lookup › RxCUI directory › RxCUI 616116

Lenalidomide 5 MG Oral Capsule [Revlimid] — RxCUI 616116

RxNorm drug concept · Semantic branded drug
RxCUI 616116 Semantic branded drug · SBD ● Current RxNorm concept 6 FDA products 12 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI616116
Official nameLenalidomide 5 MG Oral Capsule [Revlimid]
Concept typeSemantic branded drug (SBD)
RxNorm statusCurrent RxNorm concept
Also known asRevlimid 5 MG Oral Capsule
FDA products mapped6
Package NDCs mapped12
Reported Medicaid activity (SDUD)7,964 prescriptions · 27 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Lenalidomide: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • Lenalidomide is the active ingredient in both Revlimid and the generic version called Lenalidomide — they are the same medicine. Depending on your diagnosis, your doctor may prescr...
  • What exactly is lenalidomide used for — and do I need both Revlimid and the generic?
  • Because lenalidomide can cause severe birth defects or kill an unborn baby, it's only available through a strictly controlled program called the Lenalidomide REMS program. Everyone...
  • I heard this drug is really hard to get — why do I have to jump through so many hoops just to fill my prescription?
📖 Read our full Lenalidomide guide →

🕸️ Concept Web — How Lenalidomide 5 MG Oral Capsule [Revlimid] Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Lenalidomide 5 MG Oral Capsule [Revlimid] RxCUI 616116

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 1

    The active substance itself — no strength, form, or brand attached yet.

    • Lenalidomide 342369
  2. Brand names 1

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • Revlimid 337535
  3. Dose forms 9

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Lenalidomide Oral Capsule 602909
    • Lenalidomide Oral Product 1162569
    • Lenalidomide Pill 1162570
    • Lenalidomide Oral Capsule [Revlimid] 616113
    • Revlimid Oral Product 1182522
    • Revlimid Pill 1182529
    • Oral Capsule 316965
    • Oral Product 1151131
    • +1 more in this family
  4. Clinical & branded drugs 3

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

Showing up to 8 concepts per family — 13 of 14 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Lenalidomide 5 MG Oral Capsule SCD · 602912
  • Lenalidomide 5 MG SCDC · 602911
  • Lenalidomide Oral Capsule SCDF · 602909
  • Lenalidomide Oral Product SCDG · 1162569
  • Lenalidomide Pill SCDG · 1162570

Brand-Name Concepts

  • Lenalidomide 5 MG [Revlimid] SBDC · 616115
  • Lenalidomide Oral Capsule [Revlimid] SBDF · 616113
  • Revlimid Oral Product SBDG · 1182522
  • Revlimid Pill SBDG · 1182529
  • Revlimid BN · 337535

📦 FDA Products & Package NDCs

6 products · 12 package NDCs
12 package NDCs map to RxCUI 616116 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
59572-0402-00 100 CAPSULE in 1 BOTTLE (59572-402-00) Revlimid Celgene Corporation 2012-05-09
59572-0402-28 28 CAPSULE in 1 BOTTLE (59572-402-28) Revlimid Celgene Corporation 2012-05-09
59572-0405-00 100 CAPSULE in 1 BOTTLE (59572-405-00) Revlimid Celgene Corporation 2005-12-27
59572-0405-28 28 CAPSULE in 1 BOTTLE (59572-405-28) Revlimid Celgene Corporation 2009-03-03
59572-0410-00 100 CAPSULE in 1 BOTTLE (59572-410-00) Revlimid Celgene Corporation 2005-12-27
59572-0410-28 28 CAPSULE in 1 BOTTLE (59572-410-28) Revlimid Celgene Corporation 2009-03-03
59572-0415-00 100 CAPSULE in 1 BOTTLE (59572-415-00) Revlimid Celgene Corporation 2006-07-07
59572-0415-21 21 CAPSULE in 1 BOTTLE (59572-415-21) Revlimid Celgene Corporation 2006-07-07
59572-0420-00 100 CAPSULE in 1 BOTTLE (59572-420-00) Revlimid Celgene Corporation 2013-06-10
59572-0420-21 21 CAPSULE in 1 BOTTLE (59572-420-21) Revlimid Celgene Corporation 2013-06-10
59572-0425-00 100 CAPSULE in 1 BOTTLE (59572-425-00) Revlimid Celgene Corporation 2006-07-07
59572-0425-21 21 CAPSULE in 1 BOTTLE (59572-425-21) Revlimid Celgene Corporation 2009-03-03
Observed labelers: Celgene Corporation (12) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.